These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 29959758)

  • 21. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators.
    Forns J; Pottegård A; Reinders T; Poblador-Plou B; Morros R; Brandt L; Cainzos-Achirica M; Hellfritzsch M; Schink T; Prados-Torres A; Giner-Soriano M; Hägg D; Hallas J; Cortés J; Jacquot E; Deltour N; Perez-Gutthann S; Pladevall M; Reutfors J
    J Affect Disord; 2019 Apr; 249():242-252. PubMed ID: 30780117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.
    Spina E; Santoro V; D'Arrigo C
    Clin Ther; 2008 Jul; 30(7):1206-27. PubMed ID: 18691982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressants in epilepsy.
    Górska N; Słupski J; Cubała WJ; Wiglusz MS; Gałuszko-Węgielnik M
    Neurol Neurochir Pol; 2018; 52(6):657-661. PubMed ID: 30131174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.
    Coupland CA; Dhiman P; Barton G; Morriss R; Arthur A; Sach T; Hippisley-Cox J
    Health Technol Assess; 2011 Aug; 15(28):1-202, iii-iv. PubMed ID: 21810375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyponatremia associated with SSRI/NRSI: Descriptive and comparative epidemiological study of the incidence rates of the notified cases from the data of the French National Pharmacovigilance Database and the French National Health Insurance].
    Revol R; Rault C; Polard E; Bellet F; Guy C
    Encephale; 2018 Jun; 44(3):291-296. PubMed ID: 29248119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
    Oskotsky T; Maric I; Tang A; Oskotsky B; Wong RJ; Aghaeepour N; Sirota M; Stevenson DK
    JAMA Netw Open; 2021 Nov; 4(11):e2133090. PubMed ID: 34779847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C
    J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants and the risk of hyponatremia: a class-by-class review of literature.
    De Picker L; Van Den Eede F; Dumont G; Moorkens G; Sabbe BG
    Psychosomatics; 2014; 55(6):536-47. PubMed ID: 25262043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case-control and case-series analysis of a large UK primary care database.
    Gribbin J; Hubbard R; Gladman J; Smith C; Lewis S
    Drugs Aging; 2011 Nov; 28(11):895-902. PubMed ID: 22054230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
    Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
    Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.
    Morishita S; Arita S
    Hum Psychopharmacol; 2004 Aug; 19(6):405-8. PubMed ID: 15303244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic and clinical factors associated with different antidepressant treatments: a retrospective cohort study design in a UK psychiatric healthcare setting.
    Fernandes AC; Chandran D; Khondoker M; Dewey M; Shetty H; Dutta R; Stewart R
    BMJ Open; 2018 Sep; 8(9):e022170. PubMed ID: 30185574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
    Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
    Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.